Stoke Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 04, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $40,000,000
Company Info
- Founding Year
- 2018
- Founders
- Edward M. Kaye, M.D.
- Company Description
- Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
- Market
- Genetic diseases
- Location
- Bedford, MA, USA